Sofwave™, approved by U.S. FDA, "is indicated for use as a non-invasive dermatological aesthetic treatment to improve facial lines and wrinkles for subjects aged 22 and older."*
Sofwave™, approved by U.S. FDA, "is indicated for use as a non-invasive dermatological aesthetic treatment to improve facial lines and wrinkles for subjects aged 22 and older."*
Sofwave™, approved by U.S. FDA on September 9, 2019, “is indicated for use as a non-invasive dermatological aesthetic treatment to improve facial lines and wrinkles for subjects aged 22 and older.”*
* Cited from the U.S. FDA website document.
Reach out to us today and start a conversation.
86 21 6033 9588